BLOG / 🇺🇸 United States / ma activity · · daily

US Merger & Acquisition SEC Filings — November 02, 2026

USA M&A & Takeover Activity

By Gunpowder Editorial ·

26 high priority 26 total filings analysed

Executive Summary

The 26 filings reveal a surge in M&A completion activity, with 13 deals closing on November 1-2, 2026, spanning consumer health, industrial REITs, banking, and biopharma.

The largest transactions—Kimberly-Clark's acquisition of Kenvue for $3.50 cash plus 0.14625 KMB shares per share (creating a $31.6B revenue consumer health giant) and Brookfield/CPP's $5.2B take-private of LXP Industrial Trust—signal strategic consolidation and private capital deployment. SPAC activity remains robust with new IPOs (BHAV Acquisition Corp II's $100M) and business combinations (NorthStrive/Nuclea at $350M EV, FG Imperii/tZERO at $350M pre-money), though redemption risk and financing contingencies persist. Cross-border deals (Isabella/Grand River, Bank7/Century) highlight regional banking consolidation, while asset sales (Tripadvisor/TheFork for $700M, Theriva's $350K upfront+$91M milestones) show portfolio pruning. Insider activity is notably absent across filings, but capital allocation shifts are evident: Supernus/Indivior's $1.0B special dividend financed by $650M term loan raises leverage concerns, while Broadwind's $18M acquisition at 4.8x EBITDA with 3.7x pro forma leverage targets 2.0x by 2028. Overall, the period underscores a seller's market for quality assets, but integration and financing risks loom large.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from October 30, 2026.

Investment Signals (12)

  • Completed $3.50 cash + 0.14625 share acquisition of Kenvue, creating 10 billion-dollar brands and ~$2.1B run-rate synergies (~$1.9B cost, ~$500M revenue profit)

  • Brookfield/CPP (BULLISH)
    ▲

    Acquired LXP Industrial Trust for $5.2B including debt, adding 107 industrial properties (52M sq ft) to 255M sq ft global logistics platform

  • Broadwind (BWEN) (BULLISH)
    ▲

    Acquired MCM for $18M base + $7M earnout at 4.8x TTM EBITDA (23% margin), immediately accretive to EPS and margins

  • Select Water Solutions (WTTR) (BULLISH)
    ▲

    Closed $700M Pilot Water Solutions acquisition ($600M cash + 5.15M shares), adding contractual revenue and minimum volume commitments in Delaware Basin

  • All-stock merger with SSGT III at ~$500M portfolio value creates >$1B asset REIT, expands to 10 states and 3 Canadian provinces

  • Merger creates 11-product CNS portfolio with five growth drivers; $1.0B special dividend to Indivior holders financed by $650M term loan

  • Isabella Bank (ISBA) (NEUTRAL)
    ▲

    Completed acquisition of Grand River Commerce, creating $2.7B asset bank; 59.6% of target shares elected cash but prorated to 35% cap

  • Bank7 (BSVN) (BULLISH)
    ▲

    Merged with Century Financial Services, expanding to 20 branches across Oklahoma, Texas, Kansas, and New Mexico

  • Alpine Income Property Trust (PINE) (BULLISH)
    ▲

    Acquired 13-property industrial portfolio for $117.3M ($63/sq ft), 100% leased with 10.2-year WALT and rent escalators

  • Tripadvisor (TRIP) (NEUTRAL)
    ▲

    Sold TheFork to American Express for $700M cash, streamlining focus; pro forma financials due Nov 5

  • Dorchester Minerals (DMLP) (NEUTRAL)
    ▲

    Acquired 4,300 net royalty acres in Williston Basin for 1.25M units in non-taxable exchange; no cash outlay

  • Definitive agreement to merge with Nuclea Energy at $350M EV, with 15M earnout shares tied to technical and funding milestones

Risk Flags (10)

  • Supernus/Indivior↓ [HIGH RISK]
    ▼

    $1.0B special dividend financed by $650M term loan increases leverage; combined company may face integration challenges and debt service burden

  • Broadwind (BWEN) [MEDIUM RISK]
    ▼

    Pro forma net leverage at ~3.7x, well above target of 2.0x by 2028; integration and earnout risks

  • Received Nasdaq notice for failing $35M MVLS requirement; 180-day compliance period until April 28, 2027; delisting risk

  • Theriva Biologics (TOVX) [HIGH RISK]
    ▼

    Sold antibiotic enzyme portfolio for only $350K upfront against up to $91M in contingent milestones; Phase 1b/2a trial paused

  • Select Water Solutions (WTTR) [MEDIUM RISK]
    ▼

    Cash true-up provision if stock price falls below pre-closing VWAP at six-month mark; potential additional cash outflow

  • Kenvue (KVUE) [MEDIUM RISK]
    ▼

    Ceased trading; integration into Kimberly-Clark may face synergy realization risk and indebtedness from deal financing

  • Cactus Acquisition Corp 1 (CCTS) [LOW RISK]
    ▼

    44,384 shares redeemed (~$560K) despite near-unanimous extension vote; signals investor skepticism

  • tZERO merger subject to redemption risk and financing uncertainties; no PIPE committed

  • Iron Horse Acquisition II (IRHO) [MEDIUM RISK]
    ▼

    No PIPE financing committed for Electra Vehicles merger; investor presentation may not translate to capital

  • LiveRamp Holdings (RAMP) [MEDIUM RISK]
    ▼

    Filed 8-K indicating completion of disposition and charter change to shell entity with only 1,000 authorized shares; details lacking

Opportunities (10)

  • Broadwind (BWEN) (OPPORTUNITY)
    ◆

    MCM acquisition at 4.8x EBITDA with 23% margins, expected to be immediately accretive; leverage reduction target to 2.0x by 2028 could drive re-rating

  • Alpine Income Property Trust (PINE) (OPPORTUNITY)
    ◆

    Industrial portfolio acquisition at $63/sq ft with 10.2-year WALT and rent escalators; potential for NAV accretion and dividend growth

  • Select Water Solutions (WTTR) (OPPORTUNITY)
    ◆

    Pilot Water Solutions acquisition adds contractual revenue and minimum volume commitments; new $500M revolver provides liquidity

  • ◆

    Merger creates >$1B REIT with 45% unit growth and geographic diversification; potential for increased scale and cost synergies

  • NorthStrive Acquisition Corp I (NSAI)↓ (SPECULATIVE OPPORTUNITY)
    ◆

    Nuclea Energy merger at $350M EV with 15M earnout shares; advanced nuclear technology could attract ESG-focused investors

  • FG Imperii Acquisition Corp (FGII)↓ (SPECULATIVE OPPORTUNITY)
    ◆

    tZERO going public at $350M pre-money with up to $231M trust cash; tokenization infrastructure play with 62% support

  • Bank7 (BSVN) (OPPORTUNITY)
    ◆

    Century Financial merger expands footprint to New Mexico; potential for cross-selling and operational synergies

  • Isabella Bank (ISBA) (OPPORTUNITY)
    ◆

    Grand River acquisition adds Kent County/Grand Rapids market; proration results in 59.6% cash electors receiving only ~41.3% cash, reducing cash outflow

  • Tripadvisor (TRIP) (OPPORTUNITY)
    ◆

    $700M TheFork sale provides cash for core business investment or shareholder returns; pro forma financials due Nov 5 could clarify valuation

  • Dorchester Minerals (DMLP) (OPPORTUNITY)
    ◆

    Williston Basin royalty acquisition for units is non-dilutive to cash; potential for production growth and distribution increases

Sector Themes (6)

  • Consumer Health Consolidation
    ◆

    Kimberly-Clark's acquisition of Kenvue creates a $31.6B revenue consumer health leader with 10 billion-dollar brands; signals consolidation in consumer staples as companies seek scale and synergies [IMPLICATION: Further M&A likely in consumer health]

  • Industrial Real Estate Take-Private
    ◆

    Brookfield/CPP's $5.2B acquisition of LXP Industrial Trust and Alpine's $117.3M industrial portfolio purchase highlight strong private capital appetite for industrial assets with long leases and rent escalators [IMPLICATION: Public REITs undervalued vs private market]

  • Regional Bank Consolidation
    ◆

    Isabella Bank/Grand River and Bank7/Century Financial mergers reflect ongoing consolidation among community banks seeking scale and geographic diversification [IMPLICATION: More deals expected as margins compress]

  • SPAC Market Evolution
    ◆

    New SPAC IPOs (BHAV $100M) and announced mergers (NorthStrive/Nuclea, FG Imperii/tZERO) show continued activity but with heightened redemption risk and financing contingencies [IMPLICATION: Quality targets and committed capital are key]

  • Biopharma Portfolio Pruning
    ◆

    Theriva's sale of antibiotic enzyme portfolio for minimal upfront and Supernus/Indivior merger show companies divesting non-core assets and consolidating to focus on growth drivers [IMPLICATION: Divestitures and mergers to continue in biopharma]

  • Leverage-Funded Dividends
    ◆

    Supernus/Indivior's $1.0B special dividend financed by $650M term loan and Broadwind's 3.7x pro forma leverage indicate willingness to use debt for shareholder returns and acquisitions [IMPLICATION: Monitor credit metrics for deterioration]

Watch List (8)

  • Tripadvisor (TRIP)
    👁

    Q3 2026 earnings call on Nov 5 to discuss TheFork sale and pro forma financials; watch for strategic update and capital allocation plans

  • Nuclea Energy merger expected to close in 1H 2027; monitor SEC effectiveness of Form S-4, shareholder approvals, and Moltex acquisition clearances

  • tZERO merger expected to close in early 2027; watch for PIPE financing announcements and redemption levels

  • Iron Horse Acquisition II (IRHO)
    👁

    Electra Vehicles merger pending; monitor for PIPE commitment and shareholder vote

  • 180-day compliance period until April 28, 2027; watch for plan to regain Nasdaq compliance or potential delisting

  • Cactus Acquisition Corp 1 (CCTS)
    👁

    Extension to Nov 2, 2027; monitor for business combination announcement and further redemptions

  • Broadwind (BWEN)
    👁

    Integration of MCM and deleveraging progress; watch for Q4 2026 earnings for synergy realization and leverage reduction

  • Combined company begins trading as SUPN on Nov 3; watch for integration updates and debt reduction plans

Filing Analyses (26)
Alpine Income Property Trust, Inc. 8-K positive materiality 7/10

02-11-2026

Alpine Income Property Trust (NYSE: PINE) completed its previously announced acquisition of a 13-property industrial portfolio for $117.3 million, or $63 per square foot, funded with borrowings under its revolving credit facility. The portfolio spans approximately 1.9 million square feet across 209 acres in 11 states, is 100% leased to nine tenants under absolute triple-net leases, and carries a 10.2-year weighted average remaining lease term with built-in annual rent escalators. The deal adds mission-critical manufacturing and distribution assets with an attractive initial yield, though it increases leverage via revolver draws and concentrates exposure in industrial tenants across 11 states.

  • · Acquisition was funded with borrowings under the Company's revolving credit facility, adding leverage to the balance sheet
  • · Portfolio consists of mission-critical manufacturing and distribution facilities
  • · Leases are absolute triple-net with annual rent escalators built in
  • · Company is a REIT focused on single-tenant net leased commercial income properties, complemented by select commercial loan investments
  • · Forward-looking statements reference risk factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2025
Ribbon Acquisition Corp. 8-K negative materiality 6/10

02-11-2026

Ribbon Acquisition Corp. received a written notice from Nasdaq's Listing Qualifications Department on October 30, 2026, indicating it fails to meet the $35,000,000 minimum market value of listed securities (MVLS) requirement under Nasdaq Rule 5550(b)(2), with MVLS below the threshold for 30 consecutive business days (September 18–October 29, 2026). The company also does not satisfy the alternative continued listing standards under Rules 5550(b)(1) (stockholders' equity) and 5550(b)(3) (net income from continuing operations). It has a 180-day compliance period until April 28, 2027, and the notice has no immediate effect on listing, with shares continuing to trade under 'RIBB'.

  • · Company is a Cayman Islands exempted company headquartered in Tokyo, Japan, classified as a blank check company (SIC 6770)
  • · Notice received October 30, 2026; 8-K filed November 2, 2026
  • · If compliance is not regained by April 28, 2027, Nasdaq will issue written notification of delisting, after which the company may appeal to a Nasdaq Hearings Panel
  • · Company is an emerging growth company
  • · No assurance given that the company will regain or maintain compliance
CBIZ, Inc. 8-K positive materiality 9/10

02-11-2026

Grant Thornton Advisors completed its all-cash acquisition of CBIZ, Inc. for an enterprise value of $5 billion, creating the fifth-largest U.S. professional services, tax and advisory provider with over $5 billion in annual domestic revenue. The combined multinational platform now generates more than $7 billion in annual revenue with over 34,500 professionals across more than 25 countries. CBIZ is now wholly owned by Grant Thornton Advisors and its common stock (NYSE: CBZ) has ceased trading on the NYSE. Separately, CBIZ's Benefits & Insurance Services segment has been established as an independent company backed by New Mountain Capital, and a separate attest transaction involving Grant Thornton LLP and CBIZ CPAs is expected to close later this year.

  • · The transaction marks the largest of its kind in more than 25 years.
  • · CBIZ's Benefits & Insurance Services segment has been established as an independent company backed by New Mountain Capital.
  • · A separate attest transaction involving Grant Thornton LLP and CBIZ CPAs is expected to close later this year; CBIZ CPAs will remain a separate licensed public accounting firm during a transition period.
  • · New Mountain Capital led an investment in Grant Thornton Advisors in May 2024 and provided additional equity to support the acquisition.
  • · The combined organization will ultimately go to market under the Grant Thornton brand and operate through an integrated business model.
  • · Jim Peko will continue as CEO of Grant Thornton Advisors and leader of its multinational platform.
  • · The platform is currently home to 20 aligned firms stretching from the Americas across Europe and the Middle East to the Asia-Pacific region.
  • · The Grant Thornton International Limited network provides access to member firms in more than 150 global markets.
BHAV Acquisition Corp II 8-K neutral materiality 6/10

02-11-2026

BHAV Acquisition Corp II, a blank-check SPAC led by CEO Giri Devanur and CFO Chaitanya Kumar Setti, priced a $100 million IPO of 10,000,000 units at $10.00 per unit, with each unit comprising one Class A ordinary share and one right (each right convertible into 1/4 of a Class A share upon an initial business combination). Units are expected to trade on Nasdaq under 'BHAIU' from October 29, 2026, with shares and rights later separating as 'BHAI' and 'BHAIR'; the offering is expected to close October 30, 2026. The company granted the underwriter (Maxim Group LLC, sole book-runner) a 45-day option for up to 1,500,000 additional units, but no business combination target, valuation, or operating financials were disclosed, leaving the deal's ultimate outcome uncertain.

  • · Registration statement on Form S-1 (File No. 333-299203) declared effective by the SEC on October 28, 2026
  • · Units expected to begin trading on Nasdaq October 29, 2026; offering expected to close October 30, 2026
  • · Company is a blank check/SPAC with no disclosed target, deal terms, or operating financials
  • · Prospectus available from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022
DORCHESTER MINERALS, L.P. 8-K neutral materiality 6/10

02-11-2026

Dorchester Minerals, L.P. (NASDAQ-DMLP) closed its previously announced acquisition of approximately 4,300 net royalty acres across three counties in the Williston Basin, North Dakota. The deal was structured as a non-taxable contribution and exchange, with the contributing entity receiving 1,250,000 common units of the Partnership in consideration. No cash purchase price or production/revenue contribution figures were disclosed, limiting visibility into valuation and accretion.

  • · Transaction structured as a non-taxable contribution and exchange
  • · No cash purchase price, production volumes, or revenue contribution disclosed
  • · Acquired interests are in the Williston Basin, North Dakota
  • · Partnership is Dallas-based and owns interests in 28 states
  • · Common units trade on NASDAQ Global Select Market under symbol DMLP
TripAdvisor, Inc. 8-K neutral materiality 8/10

02-11-2026

Tripadvisor completed the sale of TheFork, its European online restaurant reservation and management platform, to American Express Travel Related Services Company for $700 million in an all-cash transaction on November 1, 2026, pursuant to an Equity Purchase Agreement signed August 2, 2026. The deal was a significant disposition under Item 2.01, and the company entered a 12-month Transition Services Agreement with the buyer. Pro forma financial statements are due by November 5, 2026, with discussion expected on the Q3 2026 earnings call the same day.

  • · Equity Purchase Agreement originally entered into on August 2, 2026, and filed as Exhibit 10.1 to an 8-K on August 3, 2026
  • · Unaudited pro forma condensed consolidated financial statements to be filed by amendment no later than November 5, 2026
  • · Transaction to be discussed on the Q3 2026 earnings call scheduled for November 5, 2026
  • · Forward-looking risks cited include potential unknown liabilities or tax consequences, costs of segregating technology and data platforms, and disruption of management time
Keen Vision Acquisition Corp. 8-K neutral materiality 3/10

02-11-2026

Keen Vision Acquisition Corporation (KVACU) issued a $30,000 unsecured, non-interest-bearing promissory note to its sponsor, KVC Sponsor LLC, dated October 27, 2026, and disclosed it via 8-K on November 2, 2026. The note is repayable only upon consummation of an initial business combination and terminates if no deal closes by July 27, 2027 (subject to further extension), with no interest accruing. The sponsor may convert the note into private units at $10.00 per unit, and it waives all claims against the $151,368,750 trust account.

  • · Note matures/terminates if a Business Combination does not close on or prior to July 27, 2027, as may be further extended
  • · Principal may not be prepaid without the consent of the Payee
  • · Conversion requires written notice at least one business day prior to closing of a Business Combination; no fractional units issued (cash paid instead)
  • · Note is governed by New York law with exclusive New York jurisdiction
  • · Payee waives any claim against the trust account
  • · Company's IPO prospectus is dated July 24, 2023
  • · Company address: 37 Greenbriar Drive, Summit, NJ 07901
Black Spade Acquisition III Co 8-K neutral materiality 3/10

02-11-2026

Black Spade Acquisition III Co, a Cayman Islands blank check company, issued a $200,000 unsecured, non-interest-bearing promissory note to its sponsor, Black Spade Sponsor LLC III, dated October 30, 2026. The note funds costs and expenses related to the company's proposed business combination and matures on the earlier of March 31, 2027 or the consummation of a Business Combination. No interest accrues on the principal, and the payee has waived any claims against the IPO trust account, which holds proceeds from 15,000,000 units sold at $10.00 per unit.

  • · Note is unsecured, non-interest-bearing, and prepayable at any time without penalty
  • · Maturity Date is the earlier of March 31, 2027 or the closing of a Business Combination
  • · Maximum outstanding drawdowns under the note may not exceed $200,000 at any time
  • · Sponsor must fund each Drawdown Request within five business days of receipt
  • · No individual officer, director, employee, or shareholder is personally liable for the note
  • · Payee waived all claims against the IPO trust account, precluding recourse to trust proceeds
  • · Note is governed by New York law
  • · IPO registration statement was Form S-1 (Registration No. 333-290602); final prospectus dated January 5, 2026
  • · Assignment or transfer requires prior written consent of the other party
COLONY BANKCORP INC 8-K positive materiality 7/10

02-11-2026

Colony Bankcorp completed its merger with First Reliance Bancshares (OTCQX: FSRL) effective November 1, 2026, announced November 2, 2026, expanding into South Carolina and creating a Southeast franchise with approximately $5 billion in assets across Georgia, South Carolina, and Florida. The deal adds nine First Reliance banking locations and diversifies Colony's geographic footprint, with a planned systems conversion set for mid-2027. No transaction value, deal consideration, or financial terms were disclosed in the release, and integration costs and execution risks remain outstanding.

  • · Merger effective November 1, 2026; announced November 2, 2026
  • · Colony founded in Fitzgerald, Georgia in 1975
  • · First Reliance customers to continue banking as usual through existing accounts, locations, and digital services until conversion
  • · No purchase price, deal value, or financial terms disclosed in the press release
  • · Colony common stock trades on NYSE under symbol CBAN; First Reliance on OTCQX under FSRL
  • · Forward-looking statements flag risks that cost savings and revenue synergies may be less than expected and integration may be delayed or costlier than anticipated
Kenvue Inc. 8-K neutral materiality 8/10

02-11-2026

Kenvue Inc. filed an 8-K on November 02, 2026 covering Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01 and 9.01, indicating termination of a material agreement, completion of an acquisition/disposition, and a change of control or corporate conversion. The filing includes an Amended and Restated Certificate of Formation converting the entity to Kenvue LLC, a Delaware limited liability company with its registered office at c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801, with The Corporation Trust Company as registered agent. No financial figures, transaction values, or period-over-period metrics were disclosed in the provided exhibit text.

  • · Entity converted/renamed to Kenvue LLC, a Delaware limited liability company
  • · Registered office: c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801
  • · Registered agent for service of process: The Corporation Trust Company
  • · 8-K Items triggered include 1.02 (Material Agreement Termination), 2.01 (Completion of Acquisition or Disposition), 3.01 (Notice of Delisting/Transfer), 3.03 (Material Modification to Rights of Security Holders), 5.01 (Changes in Control), 5.02 (Departure/Election of Directors or Officers), 5.03 (Amendments to Articles/Bylaws) and 8.01 (Other Events)
  • · No transaction value, consideration, or financial terms disclosed in the provided exhibit text
Theriva Biologics, Inc. 8-K mixed materiality 6/10

02-11-2026

Theriva Biologics sold its antibiotic-degrading enzyme portfolio — SYN-004 (ribaxamase), SYN-007 and SYN-006 (carbapenemase) — to Toronto-based AI-native biopharma Biossil Labs Inc., receiving only a $350,000 upfront payment at closing against potential future consideration of up to $91 million ($3 million regulatory milestones plus up to $88 million sales milestones) and low single-digit royalties capped at $250 million. Biossil assumes all future development and commercialization costs, while Theriva retains no near-term cash beyond the modest upfront, shifting its lead asset to oncolytic adenovirus VCN-01. The related Washington University Phase 1b/2a trial of SYN-004 is currently paused after completing 2 of 3 cohorts (up to 36 evaluable participants planned).

  • · Upfront cash of $350,000 is small relative to the up to $91 million in contingent milestones, which depend on Biossil achieving regulatory approvals and cumulative worldwide sales thresholds
  • · Royalties are low single-digit on net product sales and subject to a $250 million cap
  • · Washington University Phase 1b/2a trial enrollment is currently paused after completing 2 of 3 cohorts; cohort 3 (IV cefepime) has not begun
  • · Cohort 1 used IV meropenem (not metabolized by SYN-004); cohort 2 used IV piperacillin/tazobactam; a Data and Safety Monitoring Committee recommended proceeding to cohort 3
  • · Prior Phase 2b trial in 412 patients showed better gut microbiome maintenance/recovery, lower CDI incidence and reduced VRE colonization with SYN-004
  • · With the divestiture, Theriva's lead candidate becomes VCN-01, which completed a Phase 2b trial in first-line metastatic pancreatic cancer (published in Nature Medicine); retinoblastoma Phase 2/3 discussions with regulators are ongoing
  • · Biossil is a private, Toronto- and Boston-based AI-native drug developer; financial terms of any cash beyond the upfront were not disclosed
NorthStrive Acquisition Corp I. 8-K mixed materiality 8/10

02-11-2026

NorthStrive Acquisition Corp I (Nasdaq: NSAI), a $100 million IPO SPAC that went public on August 19, 2026, announced a definitive business combination agreement with advanced nuclear technology company Nuclea Energy Inc. at an implied enterprise value of $350 million, subject to closing adjustments. The combined company, to be renamed Nuclea-X Inc. and listed on Nasdaq, is expected to close in the first half of 2027, but remains contingent on multiple conditions including SEC effectiveness of the Form S-4, shareholder approvals, completion of Nuclea's pending Moltex acquisition (with U.K. NSI Act clearance and export control licenses), dissent rights not exceeding 5% of Nuclea shares, and a minimum cash condition. The deal includes 15,000,000 earnout shares tied to technical, licensing, and $100 million funding milestones within four years, while the headline $350 million valuation is subject to reductions for Nuclea indebtedness and transaction expenses above $1.5 million.

  • · NSAC I will deregister as a Cayman Islands exempted company and continue to Canada under the Canada Business Corporations Act; Nuclea will amalgamate with a wholly owned NSAC I subsidiary under the Business Corporations Act (British Columbia).
  • · Share consideration is based on a $350 million valuation, reduced by Nuclea indebtedness and debt-like items at closing and by Nuclea transaction expenses above $1.5 million, and increased by Nuclea cash at closing (excluding bridge financing proceeds) and NSAC I transaction expenses above $1.5 million, less 500,000 Class A shares to an advisor.
  • · Outstanding Nuclea options will roll over into options of the Combined Company.
  • · Earnout shares have no voting or economic rights until conversion and must be triggered within four years of closing.
  • · Closing conditions include SEC effectiveness of the Form S-4, Nasdaq listing approval, completion of the Moltex Acquisition (including U.K. National Security and Investment Act 2021 clearance and export control licenses), dissent rights not exceeding 5% of Nuclea shares, and a minimum cash condition.
  • · Houlihan Capital, LLC provided a fairness opinion to the NSAC I Board dated October 29, 2026.
  • · Nuclea shareholders holding at least 66 2/3% of shares, including Sagar Sanghera and Vinayak Ashok Gunda, entered voting agreements; NorthStrive Sponsor I LLC and Sinamor LLC entered a support agreement, and Sinamor LLC will acquire Class B ordinary shares of NSAC I.
  • · Following closing, the Combined Company is expected to be led by Josef Freundorfer as CEO and Sagar Sanghera as Executive Chairman.
  • · NSAC I is sponsored by NorthStrive Sponsor I LLC, a wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB).
  • · Nuclea is headquartered in Mississauga, Ontario; NSAC I is based in Newport Beach, California.
  • · The transaction is subject to significant uncertainties; no assurance is given that it will be consummated on the anticipated timeline or at all.
LXP Industrial Trust 8-K positive materiality 9/10

02-11-2026

Brookfield Asset Management and CPP Investments completed their all-cash acquisition of LXP Industrial Trust, valuing LXP at approximately $5.2 billion including net debt and preferred equity, with shareholders receiving $61.20 per share in cash. LXP's shares have ceased trading on the NYSE and the company is now privately held. The deal adds 107 industrial properties (~52 million sq ft) in Sunbelt and Midwest markets to Brookfield's global logistics platform of over 255 million sq ft across 850+ properties in 20 countries.

  • · LXP's shares no longer trade on the New York Stock Exchange following completion
  • · LXP properties described as benefiting from strong occupancy and long-duration leases
  • · Brookfield logistics platform spans over 850 properties in 20 countries
  • · CPP Investments manages the Canada Pension Plan Fund for more than 22 million contributors and beneficiaries
  • · CPP Investments has offices in Hong Kong, London, Mumbai, New York City, São Paulo and Sydney
Select Water Solutions, Inc. 8-K mixed materiality 8/10

02-11-2026

Select Water Solutions closed its previously announced acquisition of Pilot Water Solutions LLC, a private Delaware Basin water midstream company, on a debt-free basis for aggregate consideration of approximately $700 million — roughly $600 million in cash at closing plus 5,149,331 shares of Class A common stock. The deal adds contractual revenue, minimum volume commitments and undeveloped capacity, but carries contingent obligations: a $15 million milestone payment expected in early 2027 and a potential cash true-up if Select's stock price falls below pre-closing levels at the six-month mark. Concurrently, a new $500 million revolving credit facility became effective, replacing the prior sustainability-linked senior secured facility.

  • · Acquisition consideration includes 5,149,331 shares of Class A common stock in addition to cash
  • · One seller holds a right to a $15 million contingent payment tied to operational milestones expected in early 2027
  • · A cash true-up payment is owed to a seller if the 30-day VWAP of Select Class A stock before the six-month anniversary of closing is below the 30-day VWAP before closing — a downside price-protection feature
  • · The prior sustainability-linked senior secured credit facility was terminated and replaced by the new $500 million revolver
  • · Pilot Water's primary operations are in the Delaware Basin
  • · Closing date: November 2, 2026; filing is an 8-K with items including 1.02 (material agreement termination), 2.01 (completion of acquisition), 2.03 (new debt obligation), 3.02 and 7.01
LiveRamp Holdings, Inc. 8-K neutral materiality 8/10

02-11-2026

LiveRamp Holdings filed an 8-K covering Items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03 and 9.01, indicating completion of a disposition/acquisition transaction and related material changes to its charter and governance. The attached Exhibit 3.1 is a Fourth Amended and Restated Certificate of Incorporation authorizing only 1,000 shares of common stock (par value $0.001), a structure consistent with a post-closing shell or holding entity rather than the operating public company. No transaction consideration, financial terms, or period-over-period operating metrics were disclosed in the filing text provided.

  • · Authorized capital reduced to 1,000 total shares of common stock, par value $0.001 per share
  • · Registered office is The Corporation Trust Company, 1209 Orange Street, Wilmington, New Castle County, Delaware 19801
  • · Each share of common stock carries one vote and votes together as a single class
  • · Directors may be removed with or without cause by majority vote or written consent of holders of a majority of outstanding shares
  • · Board expressly authorized to make, alter and repeal the By-Laws
  • · Charter includes director/officer exculpation (Article IX) and indemnification (Article X) provisions
  • · Filing items include 2.01 (completion of acquisition/disposition), 3.01, 3.03, 5.01, 5.02, 5.03 and 9.01
NAVIENT CORP 8-K neutral materiality 3/10

02-11-2026

Navient Corporation filed an 8-K on November 2, 2026, disclosing a Certificate of Elimination (Exhibit 3.1) filed with the Delaware Secretary of State on October 28, 2026, eliminating its Series A Junior Participating Preferred Stock. The certificate confirms that none of the 2,000,000 authorized Preferred Shares (par value $0.20 per share, originally designated December 20, 2021) are outstanding and none will be issued, returning them to authorized but unissued preferred stock. The filing carries no financial figures or period-over-period metrics; it is a structural/corporate-housekeeping action, likely tied to termination of a shareholder rights plan, and is neutral in financial impact.

  • · Certificate of Designations originally filed with the Delaware Secretary of State on December 20, 2021
  • · Certificate of Elimination executed October 28, 2026 and disclosed via 8-K filed November 2, 2026
  • · Elimination effected pursuant to Section 151(g) of the Delaware General Corporation Law
  • · Eliminated shares return to status of authorized but unissued preferred stock, par value $0.20 per share, without designation
  • · 8-K items flagged include 1.01, 2.01, 3.01, 3.03, 5.01, 5.03 and 9.01
ISABELLA BANK CORP 8-K neutral materiality 8/10

02-11-2026

Isabella Bank Corporation completed its acquisition of Grand River Commerce, Inc. (parent of Grand River Bank) effective November 2, 2026, creating a combined company with approximately $2.7 billion in total assets, $2.0 billion in loans, and $2.3 billion in deposits as of June 30, 2026. The deal extends Isabella's footprint into Kent County and the Grand Rapids market. In merger consideration elections, holders of 59.61% of Grand River shares (5,445,895 shares) elected cash while 40.39% (3,690,634 shares) elected stock, no preference, or made no valid election; because the merger agreement caps cash at 35% of shares, cash electing holders receive cash for only ~41.280815% of their shares at $5.71 per share, with the balance in Isabella stock at 0.1413 shares per Grand River share.

  • · Merger effective November 2, 2026
  • · Cash consideration capped at 35% of Grand River shares, forcing proration for cash electors
  • · Cash electing holders receive cash for only ~41.280815% of their shares, remainder in stock
  • · Isabella Bank operates 33 locations across nine Michigan counties: Bay, Clare, Gratiot, Isabella, Kent, Mecosta, Midland, Montcalm and Saginaw
  • · Isabella Bank established in 1903, over 120 years of operation
  • · Financial figures based on data as of June 30, 2026
BROADWIND, INC. 8-K positive materiality 8/10

02-11-2026

Broadwind (Nasdaq: BWEN) acquired 100% of privately held MCM Acquisition Company for a base purchase price of $18 million plus up to a $7 million performance-based earnout tied to milestones within 14 months. MCM, an Alabama-based precision manufacturer serving the electrical Transmission & Distribution market, generated ~$16.5 million in trailing-twelve-month revenue and ~$3.7 million adjusted EBITDA (~23% margin) through June 30, 2026, implying a 4.8x TTM EBITDA multiple. The deal is expected to be immediately accretive to margins and EPS, but pro forma net leverage is elevated at ~3.7x, with management targeting 2.0x or less by year-end 2028.

  • · Transaction valued at 4.8x TTM adjusted EBITDA as of June 30, 2026 (excluding earnout)
  • · MCM founded in 1995; 30-year operating track record
  • · MCM is 100% U.S.-based and sources all raw materials domestically
  • · MCM holds sole-source or preferred supplier status across many key accounts
  • · Pro forma net debt to TTM adjusted EBITDA ~3.7x at closing
  • · Investor conference call scheduled November 3, 2026 at 11:00 a.m. ET; replay available through November 17, 2026
  • · Northland Capital Markets acted as advisor to Broadwind
  • · MCM's ~23% EBITDA margin is well above Broadwind's comparable margin
Strategic Storage Trust VI, Inc. 8-K positive materiality 8/10

02-11-2026

Strategic Storage Trust VI (SST VI) completed its all-stock merger with Strategic Storage Growth Trust III (SSGT III), valuing SSGT III's real estate portfolio at approximately $500 million and creating a combined REIT with over $1 billion in total assets. The deal adds 12 wholly-owned facilities, grows unit count by roughly 45%, and expands the U.S. footprint from seven to ten states (entering California, New Jersey and Texas). However, ownership is now diluted for legacy holders: legacy SST VI stockholders own approximately 59% of the combined company, legacy SSGT III stockholders approximately 38%, and other operating partnership unitholders approximately 3%.

  • · SST VI gains three new joint venture interests in British Columbia and Québec and beneficial interests in three DST programs owning eight properties (~5,370 units, nearly 0.7 million net rentable square feet)
  • · Combined company spans ten states and three Canadian provinces
  • · SST VI also holds joint venture interests in six operating and two developmental properties in British Columbia, Ontario and Quebec, plus one wholly-owned development property in Florida
  • · SSGT III stockholders received one share of SST VI Class A common stock for each SSGT III share
  • · SmartStop has an owned or managed portfolio of approximately 475 operating properties in 36 states, DC and Canada (~288,000 units, ~36.8 million rentable square feet)
  • · SmartStop and affiliates own or manage 70 operating properties across five Canadian provinces (~59,000 units, 6.0 million rentable square feet)
  • · This is the third REIT with more than $1 billion in assets created by the management team and its affiliates
Cactus Acquisition Corp. 1 Ltd 8-K mixed materiality 6/10

02-11-2026

Cactus Acquisition Corp. 1 Ltd held an extraordinary general meeting on October 27, 2026, where shareholders overwhelmingly approved a special resolution extending the deadline to consummate an initial business combination from November 2, 2026 to November 2, 2027, with 3,202,406 votes for and zero against. However, 44,384 Ordinary Shares were tendered for redemption, requiring approximately $560,613.65 (about $12.63 per share) to be removed from the trust account. The extension buys the SPAC another year but the redemptions signal some investor exit despite the near-unanimous vote.

  • · Meeting held October 27, 2026 at 9:00 a.m. Eastern Time at Loeb & Loeb LLP offices, 345 Park Ave, New York, and via live webcast
  • · Record date for the meeting was September 30, 2026
  • · Amendment permits the board, in its sole discretion, to elect to wind up the Company's operations on an earlier date
  • · Amendment filed with the Registrar of Companies of the Cayman Islands; copy attached as Exhibit 3.1
  • · Redemption amount excludes additional allocation for tax obligations such as franchise taxes but not excise tax
  • · Company is an emerging growth company
  • · Class A ordinary shares par value $0.0001 per share
SUPERNUS PHARMACEUTICALS, INC. 8-K mixed materiality 9/10

02-11-2026

Supernus Pharmaceuticals and Indivior completed their merger, creating Supernus, Inc., a diversified CNS biopharmaceutical company with an 11-product portfolio and five core growth drivers (SUBLOCADE, Qelbree, GOCOVRI, ONAPGO, ZURZUVAE). Legacy Indivior holders own approximately 56.5% and legacy Supernus holders approximately 43.5% of the combined company on a fully diluted basis, with Supernus stockholders receiving 1.5401 Indivior shares per share. The deal carries a $1.0 billion aggregate special cash dividend to Indivior stockholders, financed by a $650 million term loan from Citibank N.A. plus existing cash, adding leverage risk even as management touts enhanced cash flow and scale.

  • · Combined company to trade on Nasdaq Global Market under ticker SUPN beginning November 3, 2026; will trade under INDV on November 2, 2026
  • · Supernus Pharmaceuticals, Inc. will be delisted from Nasdaq as part of the closing process
  • · Global headquarters will remain in Rockville, Md.
  • · Therapeutic areas span opioid use disorder, ADHD, Parkinson's disease dyskinesia/hypomobility, postpartum depression, epilepsy, migraine, cervical dystonia, and chronic sialorrhea
  • · Remaining portion of the $1.0B dividend funded by existing cash on hand of the combined company
  • · Forward-looking statements flag integration risk and the effect of new indebtedness on financial results
FG Imperii Acquisition Corp. 8-K positive materiality 8/10

02-11-2026

tZERO Group, Inc., a tokenization infrastructure provider, will go public via a definitive business combination with FG Imperii Acquisition Corp. (Nasdaq: FGII) at a pre-money equity valuation of $350 million, including up to $25 million tied to milestone achievements. The combined company may receive up to approximately $231 million of cash held in FG Imperii's trust account (subject to redemptions and before expenses), plus a forward purchase arrangement with FG Merchant Partners LP covering up to 2.5 million shares; however, actual proceeds are uncertain given redemption risk, and the deal is not expected to close until early 2027 pending shareholder and regulatory approvals. Existing tZERO shareholders are expected to roll 100% of their equity, and support agreements cover approximately 62% of tZERO's capital on a fully diluted basis.

  • · Combined company common stock expected to trade on NYSE American under ticker "TZRO"
  • · Transaction expected to close in early 2027, subject to shareholder approvals, regulatory consents, Form S-4 effectiveness and NYSE American listing approval
  • · tZERO has operated at the intersection of blockchain and regulated securities markets since 2014
  • · tZERO operates an SEC-registered, FINRA-member broker-dealer, an ATS under Regulation ATS, and a registered transfer agent
  • · tZERO has a CFTC-registered introducing broker and DCO, with a pending DCM designation application
  • · Combined company board expected to include tZERO's CEO and other tZERO-designated directors, plus one board observer designated by FG Imperii's sponsor
  • · Chardan is exclusive financial and capital markets advisor to tZERO and lead placement agent; Imperii Securities is co-placement agent
  • · Net proceeds expected to strengthen balance sheet, expand technology and regulated infrastructure, accelerate commercial growth and fund general corporate purposes
  • · Boards of both companies unanimously approved the transaction
Iron Horse Acquisition II Corp. 8-K neutral materiality 4/10

02-11-2026

Iron Horse Acquisition II Corp. (IRHO), a Cayman Islands-domiciled SPAC listed on Nasdaq, filed an 8-K furnishing a November 2, 2026 newsletter and investor presentation from merger partner Electra Vehicles, Inc., with which it has a pending business combination agreement. The investor presentation may be used with potential investors, including for a potential PIPE financing, but no PIPE financing has been committed as of the filing date. The filing contains no financial results or transaction terms, and the business combination remains subject to shareholder approval via a proxy statement/prospectus included in a Form S-4 registration statement.

  • · No PIPE financing has been committed as of the November 2, 2026 date of the investor presentation
  • · IRHO's Annual Report on Form 10-K for the year ended November 30, 2025 was filed with the SEC on February 13, 2026
  • · A registration statement on Form S-4 containing a preliminary proxy statement/prospectus has been filed with the SEC for the business combination
  • · IRHO is an emerging growth company and a Cayman Islands corporation with IRS EIN 98-1885362
  • · Securities trade on Nasdaq under symbols IRHOU (units), IRHO (ordinary shares) and IRHOR (rights, each entitling holder to 1/10 of an ordinary share)
  • · Company was formerly named Iron Horse Acquisitions Corp. II (name change February 25, 2025) and Iron Horse Acquisition Corp. II (January 14, 2025)
  • · Forward-looking statements reference risks including failure to meet minimum cash at closing requirements, redemption levels, and Nasdaq listing standards
INDIVIOR PLC 8-K mixed materiality 9/10

02-11-2026

Supernus Pharmaceuticals and Indivior completed their merger on November 2, 2026, creating Supernus, Inc., a diversified CNS biopharmaceutical company with an 11-product portfolio and five core growth drivers (SUBLOCADE, Qelbree, GOCOVRI, ONAPGO, ZURZUVAE). Former Indivior stockholders own approximately 56.5% of the combined company while former Supernus stockholders own approximately 43.5% on a fully diluted basis. Indivior stockholders received a one-time aggregate special cash dividend of $1.0 billion, financed by a $650 million term loan from Citibank N.A. and existing cash, which adds leverage to the combined entity.

  • · Combined company begins trading on Nasdaq Global Market under ticker SUPN on November 3, 2026; trades under INDV on November 2, 2026.
  • · Supernus Pharmaceuticals, Inc. will be delisted from Nasdaq as part of the closing process.
  • · Combined company headquarters will be in Rockville, Md.
  • · Board of Directors has eight directors, four from each legacy company.
  • · The $1.0 billion special dividend was financed with a $650 million term loan plus existing cash on hand.
  • · Advisors: Cantor Fitzgerald (lead) and Wells Fargo for Supernus; Jefferies and Piper Sandler (joint) plus Citi for Indivior; Citibank provided committed financing.
Bank7 Corp. 8-K positive materiality 7/10

02-11-2026

Bank7 Corp. (NASDAQ: BSVN) completed its previously announced merger with Century Financial Services Corporation, the Santa Fe, New Mexico-based holding company for Century Bank, effective November 1, 2026. The combined organization now operates twelve Bank7 branches in Oklahoma, the Dallas/Fort Worth metro, and Kansas, plus eight Century Bank branches in New Mexico and one loan production office in Dallas. Anne Kain, Century Bank's existing CFO, was named President of Century Bank; no transaction financial terms, purchase price, or deal value were disclosed in the release.

  • · Merger effective date: November 1, 2026; announcement dated November 2, 2026
  • · No purchase price, deal value, or financial terms of the transaction were disclosed
  • · Subsidiary bank mergers still require regulatory approvals and have not yet been completed
  • · Century Bank described as having a century-long tradition of community banking in New Mexico
  • · Bank7 states it will continue pursuing strategic acquisitions and selective new branch openings
  • · Forward-looking statements flag integration risk, purchase accounting impacts, and interest rate/economic conditions
KIMBERLY CLARK CORP 8-K positive materiality 9/10

02-11-2026

Kimberly-Clark completed its acquisition of Kenvue on November 2, 2026, creating a combined consumer health and wellness leader with 10 billion-dollar brands and four new segments (North America ~$18.0B, Asia Pacific Focus Markets ~$4.3B, EMEA ~$5.0B, Enterprise Markets ~$4.3B in annual sales). Kenvue shareholders received $3.50 cash plus 0.14625 KMB shares per share, and KVUE ceased trading at market open. Management reiterates ~$2.1B run-rate synergies (~$1.9B cost synergies over three years plus ~$500M revenue-synergy profit, partially offset by ~$300M reinvestment within four years), though the filing carries no period-over-period financial results and flags integration, indebtedness and synergy-realization risks.

  • · Kenvue common stock (NYSE: KVUE) ceased trading as of market opening on November 2, 2026
  • · Three Kenvue directors joined the KMB board while Mae C. Jemison, Christa S. Quarles and Jaime A. Ramirez stepped down effective immediately
  • · Combined segment sales figures are FY2025 combined net sales recast for the proposed segment structure and are not Regulation S-X compliant pro forma information
  • · Filing flags risks including substantially increased indebtedness post-acquisition, ability to maintain credit ratings, integration costs exceeding expectations, and potential goodwill/intangible impairment
  • · KMB is a core S&P 500 component held by more than 400 ETFs and a Dividend Aristocrat with 54 consecutive years of dividend increases

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 26 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Merger & Acquisition SEC Filings

🇺🇸 More from United States

View all →